
Vivo Bio Tech . Falls to 52-Week Low of Rs.27.6 Amidst Continued Downtrend
2025-12-05 11:32:34Vivo Bio Tech . has reached a new 52-week low of Rs.27.6 today, marking a significant milestone in its ongoing price decline. The stock’s performance continues to lag behind its sector and broader market indices, reflecting persistent challenges in its financial metrics and market positioning.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.29.21 Amidst Prolonged Downtrend
2025-11-26 09:49:59Vivo Bio Tech . has reached a new 52-week low of Rs.29.21 today, marking a significant decline amid a sustained period of negative returns. The stock has been on a downward trajectory for the past ten trading sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.29.21 Amidst Continued Downtrend
2025-11-26 09:49:58Vivo Bio Tech . has reached a fresh 52-week low of Rs.29.21 today, marking a significant decline amid a sustained downward trend that has persisted over the past ten trading sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing challenges within the company’s financial and operational metrics.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:47:03Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant milestone in its ongoing downward trajectory. The stock has been on a losing streak for eight consecutive trading sessions, reflecting a cumulative return decline of 10.85% over this period, underperforming its sector by 0.29% on the day.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:52Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant decline amid an extended period of negative returns. The stock has recorded losses over the past eight consecutive trading sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:51Shares of Vivo Bio Tech . touched a fresh 52-week low of Rs.30.11 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has been under pressure, reflecting a series of financial and market factors that have influenced its performance over the past year.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:51Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past eight consecutive trading sessions, reflecting a cumulative return of -10.85% during this period, underperforming its sector by 0.29% on the day.
Read More
Vivo Bio Tech . Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:42Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant milestone in its recent price movement. The stock has been on a downward trajectory for eight consecutive trading sessions, reflecting a cumulative return decline of 10.85% during this period, underperforming its sector by 0.29% on the day.
Read More
Vivo Bio Tech . Stock Falls to 52-Week Low of Rs.30.11 Amidst Prolonged Downtrend
2025-11-24 10:46:40Vivo Bio Tech . has reached a new 52-week low of Rs.30.11 today, marking a significant decline amid an extended period of negative returns. The stock has been trading below all major moving averages and has recorded losses over the past eight consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
17-Nov-2025 | Source : BSENewspaper publication for Un-audited Financial Results for the quarter and half year ended September 30 2025.
Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half-Year Ended September 30 2025
14-Nov-2025 | Source : BSEPlease find enclosed
Board Meeting Outcome for Board Meeting Convened On November 14 2025.
14-Nov-2025 | Source : BSEplease find enclosed
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






